177Lu-DOTATATE for Recurrent Meningioma

Conditions: Recurrent Meningioma Interventions: Drug: Local standard of Care; Drug: 177Lu-DOTATATE Sponsors: European Organisation for Research and Treatment of Cancer - EORTC; Novartis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials